Feedback
Settings

Settings

Goto Application

50 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IN/Stjernschantz AND EN_TI/Prostaglandin Derivatives for the Treatment of Glaucoma or Ocular Hypertension

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 5
1.20050054723Method for the treatment of glaucoma and ocular hypertension with prostaglandin analogues without melanogenic side effect
US - 10.03.2005
Int.Class A61K 31/557
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
 Appl.No 10847254 Applicant Inventor Stjernschantz Johan

Prostaglandin-induced increased pigmentation of the iris can be avoided, or significantly reduced, when using a selective EP2 prostanoid receptor agonist in combination with an alpha-adrenergic agonist. Methods and compositions for the treatment of glaucoma and ocular hypertension are described.

2.2467410METHOD FOR TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION WITH PROSTAGLANDIN ANALGOUES WITHOUT MELANOGENIC SIDE-EFFECT
CA - 27.11.2004
Int.Class A61K 31/5575
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
5575having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha
 Appl.No 2467410 Applicant SYNPHORA AB Inventor STJERNSCHANTZ, JOHAN
Prostaglandin-induced increased pigmentation of the iris can be avoided, or significantly reduced, when using a selective EP2 prostanoid receptor agonist in combination with an alpha-adrenergic agonist. Methods and compositions for the treatment of glaucoma and ocular hypertension are described.
3.1348437Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP - 01.10.2003
Int.Class A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
 Appl.No 03014533 Applicant PHARMACIA AB Inventor STJERNSCHANTZ JOHAN W
The present invention relates to the use of certain prostaglandin derivatives for the manufacture of a medicament for the treatment of glaucoma and ocular hypertension. It also relates to a respective opthalmological composition.
4.20030181493Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US - 25.09.2003
Int.Class A61K 31/557
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
 Appl.No 10330846 Applicant Inventor Stjernschantz Johan Wilhelm

The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.

5.20030166729Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US - 04.09.2003
Int.Class A61K 31/557
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
 Appl.No 10288732 Applicant Inventor Stjernschantz Johan Wilhelm

The invention relates to opthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an opthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.

6.1310256Use of prostaglandin A or its derivatives for the treatment of psoriasis
EP - 14.05.2003
Int.Class A61K 31/557
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
 Appl.No 03000905 Applicant SYNPHORA AB Inventor STJERNSCHANTZ JOHAN
Prostaglandin A or derivatives thereof are effective to suppress cell growth and have utility in the treatment of psoriasis. The use of prostaglandin A or a derivative thereof for the manufacture of a medicament for the treatment of psoriasis, as well as a composition comprising a therapeutically active and physiologically acceptable amount thereof in a carrier.
7.1300149Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP - 09.04.2003
Int.Class A61K 31/557
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
 Appl.No 03000516 Applicant PHARMACIA AB Inventor STJERNSCHANTZ JOHAN W
The present invention relates to the use of a derivative of prostaglandin PGF for the preparation of an ophthalmological composition for the treatment of glaucoma or ocular hypertension. The present invention also relates to ophthalmological compositions.
8.1300151Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP - 09.04.2003
Int.Class A61K 31/557
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
 Appl.No 03000518 Applicant PHARMACIA AB Inventor STJERNSCHANTZ JOHAN W
The present invention relates to the use of a derivative of prostaglandin PGA, PGE or PGF for the preparation of an ophthalmological composition for the treatment of glaucoma or ocular hypertension. The present invention also relates to ophthalmological compositions.
9.1300150Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP - 09.04.2003
Int.Class A61K 31/557
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
557Eicosanoids, e.g. leukotrienes
 Appl.No 03000517 Applicant PHARMACIA AB Inventor STJERNSCHANTZ JOHAN W
The present invention relates to the use of a derivative of prostaglandin PGF for the preparation of an ophthalmological composition for the treatment of glaucoma or ocular hypertension. The present invention also relates to ophthalmological compositions.
10.20020173525Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US - 21.11.2002
Int.Class A61K 31/415
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4151,2-Diazoles
 Appl.No 10106228 Applicant STJERNSCHANTZ JOHAN WILHELM Inventor Stjernschantz Johan Wilhelm

The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.

# -